Vertebral Fracture Assessment
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Policy governing coverage and medical necessity of vertebral fracture assessment performed with dual-energy x-ray absorptiometry (DXA/DEXA), addressing BlueCHiP for Medicare and Commercial products.
No material clinical or coverage changes in this revision.
Coverage Criteria
Product-specific coverage
Coverage statements differ by product
77086 covered but not separately reimbursed
77086 not medically necessary for commercial
For Commercial Products, vertebral fracture assessment (VFA) performed with DXA without an accompanying bone mineral density study is considered not medically necessary because the evidence is insufficient to determine an effect on health outcomes.
This policy distinguishes coverage by product type. Specifically, for Commercial Products VFA using DXA when performed without a bone mineral density study lacks sufficient evidence of benefit and therefore is not medically necessary; such services may be denied.
Screening for vertebral fractures
VFA screening indication
No direct screening trials showing health outcome benefit; diagnostic accuracy variable
Coding and Definitions
| 77086 | Vertebral fracture assessment via dual-energy X-ray absorptiometry (DXA) |
Definitions
Provider Actions and Billing Notes
Prior authorization
Not applicable
BlueCHiP reimbursement limitation
Screening for vertebral fractures using dual-energy X-ray absorptiometry (DXA or DEXA), without bone density study, is covered for BlueCHiP for Medicare but is not separately reimbursed.
- BlueCHiP for Medicare: covered but not separately reimbursed
Commercial product denial risk
Screening for vertebral fractures using dual-energy X-ray absorptiometry (DXA or DEXA), without bone density study, is considered not medically necessary for Commercial products; services may be denied for Commercial products.
- Commercial products: not medically necessary — denial risk for VFA with DXA without a bone density study
Verify benefits
Benefits may vary between groups and contracts. Verify member eligibility and benefits with the appropriate Benefit Booklet, Evidence of Coverage or Subscriber Agreement prior to rendering services.
- Confirm member-specific benefits with provider call center or via subscriber documents
Verify member eligibility and benefits
This medical policy is informational and not a guarantee of payment. Benefits and eligibility are determined by the member's subscriber agreement or employer agreement. For member-specific benefit questions, contact the provider call center. Providers may not bill members for services determined to be not medically necessary unless the member has been informed and provided written agreement in advance.
Background
Vertebral fractures are common in older adults and identifying them can inform fracture-risk management; VFA performed with DXA can augment diagnostic information when obtained concomitantly with bone mineral density testing. However, when VFA is performed without a bone mineral density study the clinical benefit on health outcomes is uncertain, and the evidence does not support routine use of standalone VFA for screening in Commercial populations.
Prior Authorization
DXA/VFA — prior authorization not applicable
Prior authorization is not required for DXA/VFA under this policy; verify member benefits as coverage may vary by contract.
- CPT code referenced for VFA: 77086 (per policy coding section).
Not Covered
VFA using DXA performed without a bone mineral density study for members with Commercial Products is not covered / not medically necessary because available evidence is insufficient to demonstrate improved health outcomes when VFA is done absent a concurrent BMD test.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.